Fortitude Family Office, LLC

Family Office

Position in GILD — Gilead Sciences, Inc.

CIK 1950506 SCOTTSDALE, AZ

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$87,174

+$2,577 QoQ

Shares Held

690

+13.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#2,008

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortitude Family Office, LLC holds $6,252,480 across 11 Drug Manufacturers - General names. GILD ranks #6 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,046	$3,653,464
2	ABBV	AbbVie Inc.	4,225	$1,063,179
3	JNJ	Johnson & Johnson	1,844	$468,320
4	AMGN	Amgen Inc	1,172	$424,404
5	MRK	Merck & Co., Inc.	2,950	$379,075
6	GILD	Gilead Sciences, Inc. This page	690	$87,174
7	BMY	Bristol Myers Squibb Co	1,205	$69,432
8	BIIB	Biogen Inc.	315	$68,058

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$87,174	690	+13.7%	Shares	Sole	2026-07-20
2026-03-31	$84,597	607	+50.2%	Shares	Sole	2026-04-16
2025-12-31	$49,586	404	-14.8%	Shares	Sole	2026-01-15
2025-09-30	$52,614	474	+0.2%	Shares	Sole	2025-10-17
2025-06-30	$52,441	473	-7.1%	Shares	Sole	2025-07-15
2025-03-31	$57,033	509	-44.8%	Shares	Sole	2025-04-16
2024-12-31	$85,165	922	+11.2%	Shares	Sole	2025-01-10
2024-09-30	$69,503	829	+225.1%	Shares	Sole	2024-10-25
2024-06-30	$17,495	255	0.0%	Shares	Sole	2024-07-10
2024-03-31	$18,678	255	-29.8%	Shares	Sole	2024-04-11
2023-12-31	$29,406	363	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.